Latest Ceo Appointments News

Augustus Minerals has appointed Dr James Warren as its new CEO, bringing a wealth of exploration and corporate growth experience to lead its promising Western Australian projects. This leadership change signals a strategic push towards advancing drilling campaigns and unlocking shareholder value.

Endeavour Group faces a leadership shake-up as Executive Chairman Ari Mervis resigns, with CFO Kate Beattie appointed interim CEO ahead of a strategic refresh and new chair search. The group also provides solid F25 sales and profit guidance despite restructuring costs.

Traka Resources has announced a $2.5 million capital raise through a two-tranche placement, alongside significant board and executive changes that could reshape its strategic direction.

Lord Resources announces the resignation of CEO Andrew Taylor as exploration at the Ilgarari Copper Project advances under Georgina Clark’s management.

Tambourah Metals reports significant gold assay results extending mineralisation at Tambourah King and confirms high-grade antimony, silver, and copper at Speewah North, alongside corporate updates including a new CEO appointment and capital raising.

Future Metals NL has raised A$4.2 million and entered a strategic MOU with Zeta Resources to explore processing its Eileen Bore and Panton ores at the Savannah Mine plant, signalling a new phase of development amid rising PGM prices.

Killi Resources continues to build momentum at its Mt Rawdon West and West Tanami projects, progressing exploration and preparing for drilling while maintaining a solid cash position.

Noronex Limited reports promising new copper mineralisation from diamond drilling at its Fiesta Project and extends its strategic alliance with South32 into Botswana, alongside appointing a new CEO to spearhead growth.

Environmental Clean Technologies has announced that CEO John Tranfield will resign effective 29 October 2025, with a transition period planned to support ongoing strategic initiatives.

Holista Colltech reported steady customer receipts and a 38% surge in dietary supplement sales for 2QFY25, while progressing its high-value nano-collagen business and refreshing its leadership team.

Adrad Holdings has appointed Paul Proctor as interim CEO following Kevin Boyle's resignation, while maintaining a steady earnings forecast for FY25.

NeuroScientific Biopharmaceuticals has appointed Nathan Smith as CEO, leveraging his deep cell therapy expertise to accelerate clinical development and commercialisation of its StemSmart technology.